Ceftibuten and bactericidal kinetics comparative in vitro activity against enterobacteriaceae producing extended spectrum β-lactamases

This publication has 20 references indexed in Scilit:

• Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany
  Diagnostic Microbiology and Infectious Disease, 1991
• A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
  Infection, 1990
• Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins
  Infection, 1989
• SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams
  Antimicrobial Agents and Chemotherapy, 1989
• Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam
  European Journal of Clinical Microbiology & Infectious Diseases, 1988
• Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins
  Antimicrobial Agents and Chemotherapy, 1988
• Plasmid-Mediated -Lactamase (TEM-7) Involved in Resistance to Ceftazidime and Aztreonam
  Clinical Infectious Diseases, 1988
• Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins
  Infection, 1987
• Synthesis and biological properties of 7.BETA.-((Z)-2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid (7432-S), a new oral cephem antibiotic.
  The Journal of Antibiotics, 1987
• Simultaneous Simulation of the Serum Profiles of Two Antibiotics and Analysis of the Combined Effect against a Culture of Pseudomonas aeruginosa
  Chemotherapy, 1982